Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
04/2010
04/15/2010US20100092500 Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes
04/15/2010US20100092458 Regulation of apg8 phosphorylation and uses thereof
04/15/2010CA2737675A1 Pseudoproline dipeptides
04/14/2010EP2175273A1 Kokumi-imparting agent
04/14/2010EP2175013A1 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
04/14/2010EP2174947A1 Bioactive pre-tubulysins and use thereof
04/14/2010EP2173707A1 Pleuromutilin derivatives and their use as antimicrobials
04/14/2010EP1335901B1 Pharmaceutically active sulfanilide derivatives
04/14/2010EP0964693B1 Novel bacteriocins, transport and vector system and method of use thereof
04/14/2010CN101693736A Novel peptides
04/14/2010CN101693672A Peptidomimetic protease inhibitors
04/13/2010US7696359 Compound modified with glycerol derivative
04/13/2010US7696338 Immunotoxin fusion proteins and means for expression thereof
04/13/2010US7696328 N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor
04/13/2010US7696313 Prodrug compounds with isoleucine
04/13/2010US7696307 inhibiting cell growth and metastasis and treat cancer ; A Disintegrin And Metalloproteinase with ThromboSpondin motifs (ADAMTS)
04/13/2010US7696306 Compositions and methods for preventing or treating cancer
04/13/2010US7696152 For modulating immune activity, hepatitis infections, the extent of nephritis, and the growth of a cancer
04/13/2010US7695928 Disheveled PDZ modulators
04/13/2010US7695721 Gonadotrophins in the treatment anovulatory women
04/08/2010WO2010038323A1 Collagen peptide, dipeptide, and agent for prevention of disease
04/08/2010WO2010038041A1 Antimicrobial compounds
04/08/2010WO2010038040A1 Treatment of biofilms
04/08/2010WO2010037553A1 Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions
04/08/2010US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
04/08/2010US20100087382 Inhibitors of Hepatitis C NS3 Protease
04/08/2010DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors
04/08/2010CA2739386A1 Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions
04/08/2010CA2739174A1 Treatment of biofilms
04/08/2010CA2738974A1 Antimicrobial compounds
04/08/2010CA2732402A1 Collagen peptide, dipeptide, and agent for prevention of disease
04/07/2010EP2172475A1 Novel lipid peptide and hydrogel
04/07/2010EP2172474A1 Novel peptide and pharmaceutical use of the same
04/07/2010EP2170927A2 Biomolecule binding ligands
04/06/2010US7691967 Smart pro-drugs of serine protease inhibitors
04/06/2010US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds
04/06/2010CA2546506C Method for synthesis of perindopril and the pharmaceutically-acceptable salts thereof
04/06/2010CA2533005C Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
04/01/2010WO2010036896A1 Hepatitis c virus inhibitors
04/01/2010WO2010036837A1 Coordination of a technetium imaging complex on a bioactive apoptosis targeting agent
04/01/2010WO2010035575A1 Melanin production inhibitor and skin-whitening cosmetic
04/01/2010WO2010034724A1 Bioactive pre-tubulysins and use thereof
04/01/2010WO2009156687A3 New streptomyces barakatei strain, culture filtrate, derived active compounds and use thereof in the treatment of plants
04/01/2010WO2009142842A3 Novel macrocyclic inhibitors of hepatitis c virus replication
04/01/2010WO2009037592A3 Triazole-based aminoglycoside-peptide conjugates and methods of use
04/01/2010US20100080804 Methods of treating inflammatory disorders of the lungs
04/01/2010CA2738091A1 Bioactive pre-tubulysins and use thereof
03/2010
03/31/2010EP2168954A1 Cysteine proteases inhibitors
03/31/2010EP2167522A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/31/2010EP2167111A2 Polypeptides and methods of use
03/31/2010CN101687909A Composition for preventing or treating lung disease
03/31/2010CN101687908A Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof
03/31/2010CN101687856A Co-crystals and pharmaceutical compositions comprising the same
03/30/2010US7687454 Effectors of innate immunity determination
03/25/2010WO2010033239A1 Polymer conjugates of biphalin peptides
03/25/2010WO2010032891A1 Novel palmitoyltripeptide and anti-wrinkle cosmetic composition containing it
03/25/2010WO2010032322A1 Antiinflammatory peptide
03/25/2010WO2010031171A1 Iap bir domain binding compounds
03/25/2010US20100076175 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
03/25/2010US20100075910 Synthetic peptide amides and dimeric forms thereof
03/25/2010US20100075909 Peptide
03/25/2010US20100075899 Targeted photodynamic therapy agent
03/25/2010US20100075351 Bioluminescent detection of cyanohydroxy benzothiazole compounds
03/25/2010US20100075297 Photosensitive polypeptide and methods of their production and use
03/25/2010US20100074845 Enhanced sensitivity carbon nanotubes as targeted photoacoustic molecular imaging agents
03/24/2010EP2166109A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester
03/24/2010EP2166018A2 Antibody binding affinity ligands
03/24/2010EP2164858A1 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
03/24/2010CN101679484A Sulfur compounds as inhiibitors of hepatitis c virus NS3 serine protease
03/24/2010CN101679483A Hydrazido-peptides as inhibitors of hcv ns3-protease
03/24/2010CN101676299A Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
03/23/2010US7683033 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
03/23/2010US7683026 can be implemented with any of the stereoisomers of each of the Lysine (K), Proline (P) or Valine (V) amino acid residues
03/23/2010CA2377783C Epitopes formed by non-covalent association of conjugates
03/23/2010CA2377278C Prodrugs of carbamate inhibitors of impdh
03/23/2010CA2360795C Therapeutic compositions containing glutathione analogs
03/23/2010CA2309639C Small peptides and methods for treatment of asthma and inflammation
03/23/2010CA2290724C Glycopeptide hexapeptides
03/18/2010WO2010030343A1 Bioluminescent assays using cyanobenzothiazole compounds
03/18/2010WO2009136752A3 Novel peptide for augmenting brain-derived neutrotrophic factor (bdnf) protein expression in hippocampal neurons, hippocampal tissue and cerebral-cortex tissue
03/18/2010US20100069294 Hcv protease inhibitors and uses thereof
03/18/2010US20100068272 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
03/18/2010US20100068147 Dengue diagnosis and treatment
03/18/2010US20100068139 Methods of radiofluorination of biologically active vectors
03/17/2010EP1713822B1 Hcv ns-3 serine protease inhibitors
03/17/2010EP1513814B1 Novel piperidine compound
03/17/2010EP1385870B1 Peptides as ns3-serine protease inhibitors of hepatitis c virus
03/17/2010CN101671335A Cytotoxins, prodrugs, linkers and stabilizers useful therefor
03/16/2010US7678782 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
03/16/2010US7678765 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
03/16/2010US7678760 Inhibitors of Memapsin 2 and use thereof
03/11/2010WO2010027326A1 Peptide nucleic acid monomers and oligomers
03/11/2010WO2010025510A1 Libraries of peptide conjugates and methods for making them
03/11/2010WO2010006755A3 Cyclic polyamines for binding phosphatidylserine
03/11/2010US20100063252 Processes and intermediates
03/11/2010US20100063095 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/11/2010US20100062052 Peptide-based compounds as new inhibitors of metalloectopeptidases, compositions comprising said compounds and their pharmaceutical and cosmetic uses
03/10/2010EP2161277A2 Asymmetric synthesis of peptides
03/10/2010EP2161268A1 Carbacephem beta-lactam compounds for the treatment of bacterial infections
03/10/2010EP2160404A1 Azapeptides as cd36 binding compounds
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 307